Thomas MR, Angiolillo DJ, Bonaca MP, Ajjan RA, Judge HM, Rollini F, Franchi F, Ahsan AJ, Bhatt DL, Kuder JF, Steg PG, Cohen M, Muthusamy R, Sabatine MS and Storey RF. Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status. Thrombosis and Haemostasis, 2017; in press.
Gwyn JCV, Thomas MR and Kirchhof P. Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A viewpoint. European Heart Journal Cardiovascular Pharmacotherapy, 2017; in press.
Thomas MR and Lip GYH. Novel risk markers and risk assessments for cardiovascular disease. Circulation Research, 2016; 120:133-149.
Thomas MR and Storey RF. Clinical significance of residual platelet reactivity in patients treated with P2Y12 inhibitors. Vascular Pharmacology, 2016; 84: 25-27.
Thomas MR,Morton AC, Hossain R, Chen B, Luo L, Shahari N, Hua P, Beniston RG, Judge HM and Storey RF (2016) Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction. Thrombosis and Haemostasis, 2016; 116: 96-102.
Storey RF, Angiolillo DJ, Bonaca MP, Thomas MR, Judge HM, Rollini F, Franchi F, Ahsan AJ, Bhatt DL, Kuder JF, Steg PG, Cohen M, Muthusamy R, Braunwald E and Sabatine MS. Platelet inhibition with ticagrelor 60 mg compared with 90 mg twice-daily in the PEGASUS-TIMI 54 study. Journal of the American College of Cardiology 2016; 67:1145-54.
Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, Ecob R, Judge HM, Khan H, West LE, Dockrell DH, Sabroe I and Storey RF. Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arteriosclerosis, Thrombosis and Vascular Biology 2015; 35:2562-70.
Thomas MR and Storey RF. The role of platelets in inflammation. Thrombosis and Haemostasis 114: 449-58.
Grove EL, Wurtz M, Thomas MR and Kristensen D. Current antiplatelet therapy in acute coronary syndromes. Expert Opinion in Pharmacotherapy 2015; 16: 2133-47.
Thomas MR and Storey RF. Effect of P2Y12 inhibitors on inflammation and immunity. Thrombosis and Haemostasis 2015; 114: 490-7.